US Stock MarketDetailed Quotes

CLOVW CLOVER HEALTH INVESTMENTS CORP C/WTS 21/04/2025(TO PUR COM)

Watchlist
  • 0.000
  • 0.0000.00%
Close Jul 26 09:30 ET
0Market Cap0.00P/E (TTM)

CLOVER HEALTH INVESTMENTS CORP C/WTS 21/04/2025(TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q2)Jun 30, 2020
(Q1)Mar 31, 2020
(Q4)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-584.85%-64.16M
-149.81%-92.87M
-2.23M
13.23M
-37.18M
-17.63K
Net income from continuing operations
-5,978.42%-317.61M
-71.92%-48.42M
---6.74M
--5.4M
---28.16M
---17.63K
Operating gains losses
2,827.71%134.5M
-610.14%-85.43M
----
--4.59M
---12.03M
----
Depreciation and amortization
-22.88%118K
31.15%160K
----
--153K
--122K
----
Other non cash items
-99.65%43K
32.56%13.71M
---117.26K
--12.27M
--10.34M
----
Change In working capital
810.99%75.77M
-65.56%-15.61M
--4.63M
---10.66M
---9.43M
--0
-Change in receivables
-6,320.96%-425.45M
-29.25%-18.67M
----
---6.63M
---14.45M
----
-Change in prepaid assets
----
----
---299.67K
----
----
--0
-Change in payables and accrued expense
273,591.62%457.07M
152.14%2.37M
--4.93M
--167K
---4.55M
--0
-Change in other current assets
566.76%9.19M
-5,949.51%-12.05M
----
--1.38M
--206K
----
-Change in other current liabilities
892.62%14.38M
-173.17%-862K
----
--1.45M
--1.18M
----
-Change in other working capital
767.13%42.87M
66.23%13.61M
----
---6.43M
--8.19M
----
Cash from discontinued investing activities
Operating cash flow
-584.85%-64.16M
-149.81%-92.87M
---2.23M
--13.23M
---37.18M
---17.63K
Investing cash flow
Cash flow from continuing investing activities
1,306.42%170.87M
-412.05%-257.48M
-828M
-14.16M
82.51M
0
Net PPE purchase and sale
13.57%-191K
59.09%-99K
----
---221K
---242K
----
Net investment purchase and sale
1,326.91%171.06M
-411.02%-257.38M
----
---13.94M
--82.75M
----
Net other investing changes
----
----
---828M
----
----
----
Cash from discontinued investing activities
Investing cash flow
1,306.42%170.87M
-412.05%-257.48M
---828M
---14.16M
--82.51M
--0
Financing cash flow
Cash flow from continuing financing activities
-513.59%-25.47M
151,356.62%662.5M
858.23M
-4.15M
-438K
17.63K
Net issuance payments of debt
-460.47%-25.91M
-11.65%-5.02M
--806.21K
---4.62M
---4.5M
--0
Net common stock issuance
-7.64%435K
727.10%1.28M
--813.63M
--471K
--155K
--0
Proceeds from stock option exercised by employees
----
----
--16.4M
----
----
--0
Net other financing activities
--0
16,970.00%666.24M
--27.4M
--0
--3.9M
--17.63K
Cash from discontinued financing activities
Financing cash flow
-513.59%-25.47M
151,356.62%662.5M
--858.23M
---4.15M
---438K
--17.63K
Net cash flow
Beginning cash position
259.58%404.51M
36.61%92.35M
--0
--112.49M
--67.6M
--0
Current changes in cash
1,698.58%81.24M
595.29%312.16M
--28M
---5.08M
--44.9M
----
End cash Position
352.23%485.75M
259.58%404.51M
--28M
--107.41M
--112.49M
--0
Free cash flow
-594.55%-64.35M
-148.46%-92.97M
---2.23M
--13.01M
---37.42M
---17.63K
Currency Unit
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q2)Jun 30, 2020(Q1)Mar 31, 2020(Q4)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -584.85%-64.16M-149.81%-92.87M-2.23M13.23M-37.18M-17.63K
Net income from continuing operations -5,978.42%-317.61M-71.92%-48.42M---6.74M--5.4M---28.16M---17.63K
Operating gains losses 2,827.71%134.5M-610.14%-85.43M------4.59M---12.03M----
Depreciation and amortization -22.88%118K31.15%160K------153K--122K----
Other non cash items -99.65%43K32.56%13.71M---117.26K--12.27M--10.34M----
Change In working capital 810.99%75.77M-65.56%-15.61M--4.63M---10.66M---9.43M--0
-Change in receivables -6,320.96%-425.45M-29.25%-18.67M-------6.63M---14.45M----
-Change in prepaid assets -----------299.67K----------0
-Change in payables and accrued expense 273,591.62%457.07M152.14%2.37M--4.93M--167K---4.55M--0
-Change in other current assets 566.76%9.19M-5,949.51%-12.05M------1.38M--206K----
-Change in other current liabilities 892.62%14.38M-173.17%-862K------1.45M--1.18M----
-Change in other working capital 767.13%42.87M66.23%13.61M-------6.43M--8.19M----
Cash from discontinued investing activities
Operating cash flow -584.85%-64.16M-149.81%-92.87M---2.23M--13.23M---37.18M---17.63K
Investing cash flow
Cash flow from continuing investing activities 1,306.42%170.87M-412.05%-257.48M-828M-14.16M82.51M0
Net PPE purchase and sale 13.57%-191K59.09%-99K-------221K---242K----
Net investment purchase and sale 1,326.91%171.06M-411.02%-257.38M-------13.94M--82.75M----
Net other investing changes -----------828M------------
Cash from discontinued investing activities
Investing cash flow 1,306.42%170.87M-412.05%-257.48M---828M---14.16M--82.51M--0
Financing cash flow
Cash flow from continuing financing activities -513.59%-25.47M151,356.62%662.5M858.23M-4.15M-438K17.63K
Net issuance payments of debt -460.47%-25.91M-11.65%-5.02M--806.21K---4.62M---4.5M--0
Net common stock issuance -7.64%435K727.10%1.28M--813.63M--471K--155K--0
Proceeds from stock option exercised by employees ----------16.4M----------0
Net other financing activities --016,970.00%666.24M--27.4M--0--3.9M--17.63K
Cash from discontinued financing activities
Financing cash flow -513.59%-25.47M151,356.62%662.5M--858.23M---4.15M---438K--17.63K
Net cash flow
Beginning cash position 259.58%404.51M36.61%92.35M--0--112.49M--67.6M--0
Current changes in cash 1,698.58%81.24M595.29%312.16M--28M---5.08M--44.9M----
End cash Position 352.23%485.75M259.58%404.51M--28M--107.41M--112.49M--0
Free cash flow -594.55%-64.35M-148.46%-92.97M---2.23M--13.01M---37.42M---17.63K
Currency Unit USDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg